Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma

NCT01709253 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01709253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01709253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2015
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma